Activation of immune blood biomarkers from interferon gamma pathway distinguished long term survivors (>=2 years) from ...

Lung cancer remains the leading cause of cancer-related mortality in the United States and worldwide. Despite advances in ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.

The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...

The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...

A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO ...

Suvemcitug combined with chemotherapy significantly improved PFS and OS in platinum-resistant recurrent ovarian cancer, nearly doubling median PFS and extending median OS. The trial demonstrated ...

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients ...

Although 76% respondents reported encountering medical misinformation, that exposure was not significantly associated with clinically significant fear of cancer recurrence or self-reported treatment ...

Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developersCHICAGO, Jan. 15, 2026 /PRNewswire/ -- A new consensus document ...

Cervical cancer remains one of the biggest yet most preventable threats to women’s health. With the right mix of vaccination, ...